Skip to main content

Oosthuizen Johannes Jacobus's Form 4 filing

Merck & Co., Inc. (MRK) · filed Nov 1, 2022

Accession no.
0001127602-22-024599
Filed
Nov 1, 2022
Trade date
Oct 28-30, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $364.1K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Oosthuizen Johannes JacobusCIK 0001916310Officer (President, U.S. Market)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 28, 2022Common StockSSaleDisposed−3,633$100.21−$364,062.9310,880.88Direct
Oct 30, 2022Common StockMOption exerciseAcquired+913$100.77+$92,003.0111,793.88Direct
Oct 30, 2022Common StockFTax withholdingDisposed−450$100.77−$45,346.511,343.88Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 30, 2022Common StockMOption exerciseDisposed−913$0.00$0915Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)